Lataa...
Complications associated with immunotherapy for brain metastases
PURPOSE OF REVIEW: Median survival after the diagnosis of brain metastases has historically been on the order of months. With the recent development of immune checkpoint inhibitors, intracranial activity and durable responses have been observed in brain metastases on multiple phase 2 clinical trials...
Tallennettuna:
| Julkaisussa: | Curr Opin Neurol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398556/ https://ncbi.nlm.nih.gov/pubmed/31577604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WCO.0000000000000756 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|